McKesson 'exploring sale of entire UK business'
LloydsPharmacy parent company McKesson is potentially seeking to offload all of its European operations, Bloomberg has reported.
The business news website reported yesterday that the US corporation, which owns LloydsPharmacy along with drugs wholesaler AAH and online pharmacy Echo, was “exploring a sale of its European business” that would reverse its $8.3bn purchase of Celesio AG in 2014.
Texas-based McKesson is reportedly exploring a sale of its operations in continental Europe to German pharmaceutical giant Phoenix, and is separately looking to offload its UK business “to a private equity firm”.
This follows earlier speculation in February that McKesson was planning to sell the Lloyds estate.
The sale of the UK and continental European businesses could be worth $3 to $4bn, Bloomberg speculated.
“It’s been a big-time underperformer and management distraction for a while, so I think they’re focusing on their core business in the U.S.,” Bloomberg Intelligence analyst Jonathan Palmer said.
LloydsPharmacy, which according to its website operates across 1,400 UK sites and employs over 17,000 people, has faced financial difficulties in recent years due to Government funding cuts.
After a closure programme that saw around 200 stores divested, McKesson announced last August that it was once more considering closing a “small number” of LloydsPharmacy stores.
A spokesperson for McKesson UK told Pharmacy Network News: “Our policy is not to comment on speculation.”
Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Drug companies fined £260m for "excessive and unfair" price hikes to hydrocortisone tablets over a 10 year period.
1 Min Article
RPS calls for action on women's health inequalities
Action is needed to reduce the inequalities faced by women when accessing health services, the Royal Pharmaceutical Society has said.
1 Min Article
DH sets ambitious targets for winter flu programme
The Department of Health and Social Care announces that it aims to vaccinate 85 per cent of people aged 65 and over against influenza.
1 Min Article
Let's talk tech: Using technology to drive your business
This training offers insights into making the most of technology and the commercial opportunities this can offer your business.
8 Min Module
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
10 Min Module